Loss of signal transducer and activator of transduction 4 or 6 signaling contributes to immune cell morbidity and mortality in sepsis

Intensive Care Medicine

Volumn 31, Issue 11, 2005, Pages 1564-1569

  Song, Grace Y ^a   Chung, Chun Shiang ^a   Rhee, Rebecca J ^a   Cioffi, William G ^a   Ayala, Alfred ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Cecal ligation and puncture; Lymphocyte; Macrophage; Mouse; Th1 vs. Th2

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; STAT4 PROTEIN; STAT6 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOCOMPETENT CELL; MACROPHAGE; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; SEPSIS; SIGNAL TRANSDUCTION; SPLEEN CELL; SURVIVAL; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANIMALS; CYTOKINES; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; SEPSIS; SIGNAL TRANSDUCTION; SPLEEN; STAT4 TRANSCRIPTION FACTOR; STAT6 TRANSCRIPTION FACTOR; T-LYMPHOCYTES;

EID: 27744458344     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-005-2793-z     Document Type: Article

References (33)

1. Mannick JA (1993) Trauma, sepsis and immune defects. In: Faist E, Meakins JL, Schildberg FW (eds) Host defense dysfunction in trauma, shock and sepsis.- Springer, Berlin Heidelberg New York, pp 15-21
2. Ayala A, Deol ZK, Lehman DL, Herdon CD, Chaudry IH (1994) Polymicrobial sepsis but not low dose endotoxin infusion causes decreased splenocyte IL-2/IFN-gamma release while increasing IL-4/IL-10 production. J Surg Res 56:579-585
3. O'Sullivan ST, Lederer JA, Horgan AF, Chin DHL, Mannick JA, Rodrick ML (1995) Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 222:482-492
4. DiPiro JT, Howdieshell TR, Goddard JK, Callaywa DB, Hamilton RG, Mansberger AR (1998) Association of interleukin-4 plasma levels with traumatic injury and clinical course. Arch Surg 130:1159-1163
5. Ferguson NR, Galley HF, Webster NR (1999) T helper subset ratios in patients with severe sepsis. Intensive Care Med 25:106-109
6. Stanilova SA, Karakolev ZT, Dimov GS, Dobreva ZG, Miteva LD, Slavov ES, Stefanov CS, Stanilov NS (2005) High interleukin 12 and low interleukin 10 production after in vitro stimulation detected in sepsis survivors. Intensive Care Med 31:401-407
7. Song GY, Chung CS, Chaudry IH, Ayala A (2000) IL-4-induced activation of the Stat6 pathway contributes to the suppression of cell-mediated immunity and death in sepsis. Surgery 128:133-138
8. Biron CA, Gazzinelli RT (1995) Effect of IL-12 on immune responses to microbial infections: a key mediator in regulating diseases outcome. Curr Opin Immunol 7:485-496
9. O'Suilleabhain C, O'Sullivan ST, Kelly JL, Lederer J, Mannick JA, Rodrick ML (1996) Interleukin-12 treatment restores normal resistance to bacterial challenge after burn injury. Surgery 120:290-296
10. Steinhauser ML, Hogaboam CM, Lukacs NW, Strieter RM, Kunkel SL (1999) Multiple roles for IL-12 in a model of acute septic peritonitis. J Immunol 162:5437-5443
11. Matsukawa A, Kaplan MH, Hogaboam CM, Lukacs NW, Kunkel SL (2001) Pivotal role of signal transducer and activator of transcription (Stat)4 and Stat6 in the innate immune response during sepsis. J Exp Med 193:679-688
12. Godshall CJ, Lentsch AB, Peyton JC, Scott MJ, Cheadle WG (2001) STAT4 is required for antibacterial defense but enhances mortality during polymicrobial sepsis. Clin Diagn Lab Immunol 8:1044-1048
13. Nunez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ (1990) Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 144:3602-3610
14. Barriere SL, Lowry SF (1995) An overview of mortality risk prediction in sepsis. Crit Care Med 23:376-393
15. Abraham E (1999) Why immunomodulatory therapies have not worked in sepsis. Intensive Care Med 25:556-566
16. Deitch EA (1998) Animal models of sepsis and shock: a review and lessons learned. Shock 1998 9:1-11
17. Ayala A, Perrin MM, Kisala JM, Ertel W, Chaudry IH (1992) Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophage to release inflammatory mediators (IL-1, IL-6 and TNF). Circ Shock 36:191-199
18. Baker CC, Chaudry IH, Gaines HO, Baue AE (1983) Evaluation of factors affecting mortality rate after sepsis in murine cecal ligation and puncture model. Surgery 94:331-335
19. Meldrum DR, Ayala A, Perrin MM, Ertel W, Chaudry IH (1991) Diltiazem restores IL-2, IL-3, IL-6 and IFN-gamma synthesis and decreases susceptibility to sepsis following hemorrhage. J Surg Res 51:158-164
20. Ayala A, Lehman DL, Herdon CD, Chaudry IH (1994) Mechanism of enhanced susceptibility to sepsis following hemorrhage: interleukin (IL)-10 suppression of T-cell response is mediated by eicosanoid induced IL-4 release. Arch Surg 129:1172-1178
21. Godshall CJ, Scott MJ, Peyton JC, Gardner SA, Cheadle WG (2002) Genetic background determines susceptibility during murine septic peritonitis. J Surg Res 102:45-49
22. Song GY, Chung CS, Chaudry IH, Ayala A (1999) What is IL-10's role in polymicrobial sepsis: anti-inflammatory agent or immune suppressant? Surgery 126:378-383
23. Lederer JA, Rodrick ML, Mannick JA (1999) The effects of injury on the adaptive immune response. Shock 11:153-159
24. Ayala A, Chung CS, Song GY, Grutkoski PS, Simms HH (2003) Down-regulation of the immune response. In: Linden P, Doughty LA (eds) Molecular & cellular biology of critical care medicine.-. Kluwer, Norwell, pp 41-78
25. Ayala A, Chung CS, Song GY (1999) Lymphocyte activation, anergy, and apoptosis in polymicrobial sepsis. In: Marshall JC, Cohen J (eds) Immune response in the critically ill- Springer, Berlin Heidelberg New York, pp 227-245
26. Hotchkiss RS, Karl IE (2003) Medical progress: the pathophysiology and treatment of sepsis. N Engl J Med 348:138-150
27. Leonard WL, O'Shea JJ (1998) Jaks and Stats: biological implications. Annu Rev Immunol 16:293-322
28. Kaplan MH, Grusby MJ (1998) Regulation of T helper cell differentiation by STAT molecules. J Leukoc Biol 64:2-5
29. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T, Akira S (1996) Essential role of Stat6 in IL-4 signaling. Nature 380:627-630
30. Tong L, Pav S, White DM, Rogers S, Crane KM, Cywin CL, Brown ML, Pargellis CA (1997) A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket. Nat Struct Biol 4:311-318
31. Ebong S, Call D, Nemzek J, Bolgos G, Newcomb D, Remick D (1999) Immunopathologic alterations in murine models of sepsis of increasing severity. Infect Immun 67:6603-6610
32. Zellweger R, Wichmann MW, Ayala A, Stein S, DeMaso CM, Chaudry IH (1997) Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. Crit Care Med 25:106-110
33. Zellweger R, Ayala A, Chaudry IH (1998) Predisposing factors: effects of sex, nutritional factors and age on immunity following shock and sepsis. In: Redl H, Schlag G (eds) Cytokines in severe sepsis and septic shock. Birkhauser, Basel, pp 57-77